Market Cap 242.52M
Revenue (ttm) 210.78M
Net Income (ttm) 65.63M
EPS (ttm) N/A
PE Ratio 7.89
Forward PE N/A
Profit Margin 31.14%
Debt to Equity Ratio 0.00
Volume 120,800
Avg Vol 138,330
Day's Range N/A - N/A
Shares Out 37.95M
Stochastic %K 54%
Beta -0.11
Analysts Strong Sell
Price Target $20.50

Company Profile

Entrada Therapeutics, Inc., a clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. The company's EEV platform develops products based on oligonucleotide, enzyme, and antibody-conjugated EEV peptides. Its therapeutic candidates, which include ENTR-601-44 that is in Phase 1 clinical trial for the treatment of Duchenne muscular dystrophy; and VX-670, which is in Phase 1/2 clinical trial for the treatment of...

Industry: Biotechnology
Sector: Healthcare
Phone: 857 520 9158
Address:
One Design Center Place, Suite 17- 500, Boston, United States
outlawinvestor1
outlawinvestor1 Jul. 26 at 1:49 PM
$TRDA I’ve started a position at these levels. Clinical stage biotech with minimal spend, partnership and licensing revenues from a strong rare disease biotech player trading below cash. Another potential headwind that seems to have missed entrada so far is that they’re delivering a gene therapy without the potential/perceived harm of AAV viral vectors (eg $SRPT). Will buy/build more, if it dips further. My only critique is that they don’t give guidance on future trial readouts in their corporate pdf so not sure when the catalyst events will take place.
0 · Reply
Tradr1205
Tradr1205 Jul. 15 at 4:45 PM
$TRDA Bought some more. This is over-blown. Reversal forthcoming
2 · Reply
VinWeezel
VinWeezel Jul. 15 at 3:59 PM
$TRDA prolly more 5am ventures selling-Market selling tiny bits into 0 volume. Downward pressure. Not ideal days here.
2 · Reply
Tradr1205
Tradr1205 Jul. 11 at 6:01 AM
$TRDA Bought a nice chunck before the market closed. I think we're trading back above $7 in the am
0 · Reply
Goosem4n
Goosem4n Jul. 10 at 5:48 PM
$TRDA anyone shorting this hasn't checked the balance sheet.
1 · Reply
VinWeezel
VinWeezel Jul. 10 at 12:24 AM
$TRDA anyone here at all? Turda rockets or no?
1 · Reply
VinWeezel
VinWeezel Jun. 27 at 8:33 PM
$TRDA 400,000 shares traded ah and no price movement
0 · Reply
VinWeezel
VinWeezel Jun. 25 at 4:46 PM
$TRDA https://www.tradingview.com/news/tradingview:da469c2620fe4:0-entrada-therapeutics-director-kim-peter-s-acquires-25-000-shares/ this was repoted again last week cause he filed wrong. He bought 25,000 two days in a row. But how did he pay 14 in may when price was 9? This guy is literally a genius. I’m adding.
1 · Reply
valueforme
valueforme Jun. 17 at 1:19 AM
$TRDA Forgotten stock. Depending on what DYN has to say tomorrow, I might consider buying here
1 · Reply
VinWeezel
VinWeezel May. 28 at 5:54 PM
$TRDA https://www.stocktitan.net/news/TRDA/entrada-therapeutics-receives-authorization-in-the-european-union-to-oko6tip1t5oz.html
0 · Reply
Latest News on TRDA
Entrada Therapeutics: Cash-Rich Innovator With Asymmetric Upside

Feb 19, 2025, 11:31 AM EST - 5 months ago

Entrada Therapeutics: Cash-Rich Innovator With Asymmetric Upside


Entrada Therapeutics: Early Stage But Interesting

Aug 3, 2023, 6:39 PM EDT - 2 years ago

Entrada Therapeutics: Early Stage But Interesting


Entrada Therapeutics shares jump on collaboration with Vertex

Dec 8, 2022, 8:24 AM EST - 2 years ago

Entrada Therapeutics shares jump on collaboration with Vertex


outlawinvestor1
outlawinvestor1 Jul. 26 at 1:49 PM
$TRDA I’ve started a position at these levels. Clinical stage biotech with minimal spend, partnership and licensing revenues from a strong rare disease biotech player trading below cash. Another potential headwind that seems to have missed entrada so far is that they’re delivering a gene therapy without the potential/perceived harm of AAV viral vectors (eg $SRPT). Will buy/build more, if it dips further. My only critique is that they don’t give guidance on future trial readouts in their corporate pdf so not sure when the catalyst events will take place.
0 · Reply
Tradr1205
Tradr1205 Jul. 15 at 4:45 PM
$TRDA Bought some more. This is over-blown. Reversal forthcoming
2 · Reply
VinWeezel
VinWeezel Jul. 15 at 3:59 PM
$TRDA prolly more 5am ventures selling-Market selling tiny bits into 0 volume. Downward pressure. Not ideal days here.
2 · Reply
Tradr1205
Tradr1205 Jul. 11 at 6:01 AM
$TRDA Bought a nice chunck before the market closed. I think we're trading back above $7 in the am
0 · Reply
Goosem4n
Goosem4n Jul. 10 at 5:48 PM
$TRDA anyone shorting this hasn't checked the balance sheet.
1 · Reply
VinWeezel
VinWeezel Jul. 10 at 12:24 AM
$TRDA anyone here at all? Turda rockets or no?
1 · Reply
VinWeezel
VinWeezel Jun. 27 at 8:33 PM
$TRDA 400,000 shares traded ah and no price movement
0 · Reply
VinWeezel
VinWeezel Jun. 25 at 4:46 PM
$TRDA https://www.tradingview.com/news/tradingview:da469c2620fe4:0-entrada-therapeutics-director-kim-peter-s-acquires-25-000-shares/ this was repoted again last week cause he filed wrong. He bought 25,000 two days in a row. But how did he pay 14 in may when price was 9? This guy is literally a genius. I’m adding.
1 · Reply
valueforme
valueforme Jun. 17 at 1:19 AM
$TRDA Forgotten stock. Depending on what DYN has to say tomorrow, I might consider buying here
1 · Reply
VinWeezel
VinWeezel May. 28 at 5:54 PM
$TRDA https://www.stocktitan.net/news/TRDA/entrada-therapeutics-receives-authorization-in-the-european-union-to-oko6tip1t5oz.html
0 · Reply
VinWeezel
VinWeezel May. 25 at 3:42 PM
$TRDA 16 this shortened week
0 · Reply
xrichsayzx88
xrichsayzx88 May. 20 at 6:33 PM
0 · Reply
JarvisFlow
JarvisFlow May. 20 at 11:00 AM
HC Wainwright & Co. updates rating for Entrada Therapeutics ( $TRDA ) to Buy, target set at 20.
0 · Reply
VinWeezel
VinWeezel May. 18 at 11:54 AM
$TRDA lets go to 16 this week 😬
0 · Reply
Uneducated_Trader
Uneducated_Trader May. 15 at 1:46 PM
0 · Reply
Armonica423
Armonica423 May. 10 at 5:20 PM
$TRDA Big exposure for CYDY at 3 oncology conferences this coming week, do your dd research
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee May. 8 at 11:17 AM
$TRDA Entrada Therapeutics Q1 EPS $(0.42) Beats $(0.76) Estimate, Sales $20.56M Beat $10.17M Estimate
0 · Reply
maizeblue22
maizeblue22 Apr. 4 at 2:50 PM
$TRDA promising skeleton key-like tech, beat up by a red market. This is a steal at this SP
0 · Reply
Avocado_smash
Avocado_smash Apr. 1 at 4:21 PM
$TRDA 👇
0 · Reply
JarvisFlow
JarvisFlow Mar. 31 at 11:30 AM
HC Wainwright & Co. updates rating for Entrada Therapeutics ( $TRDA ) to Buy, target set at 20.
0 · Reply
Avocado_smash
Avocado_smash Mar. 30 at 4:14 PM
$TRDA PT 9.35 and lower low.
0 · Reply
TwongStocks
TwongStocks Mar. 17 at 2:45 PM
$CAPR $TRDA Both companies will take part in a panel at the Roth Annual Conference today. <<Opportunities and Challenges in Duchenne Muscular Dystrophy>> 12:00pm ET/9:00am PT https://wsw.com/webcast/roth50/
1 · Reply